Tran B. Nguyen - 28 Jul 2026 Form 4 Insider Report for PROTHENA CORP PUBLIC LTD CO (PRTA)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
30 Jul 2026, 20:32:28 UTC
Prior SEC filing
05 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael J. Isaacs, as Attorney-in-Fact for Tran B. Nguyen

Key filing fact

Tran B. Nguyen filed Form 4 for PROTHENA CORP PUBLIC LTD CO (PRTA) on 30 Jul 2026.

Key facts

  • This page summarizes Tran B. Nguyen's Form 4 filing for PROTHENA CORP PUBLIC LTD CO (PRTA).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 30 Jul 2026, 20:32.

Change

  • Previous filing in this sequence was filed on 05 Mar 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001457013 Primary reporting owner

Nguyen Tran

Relationship
Chief Strategy Officer and CFO
Address
C/O PROTHENA BIOSCIENCES INC, 1800 SIERRA POINT PARKWAY, BRISBANE
Signature
/s/ Michael J. Isaacs, as Attorney-in-Fact for Tran B. Nguyen
Signature date
30 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PRTA transaction

Ordinary Shares, par value $0.01 per share

Options Exercise

Transaction value
Shares
+57,000
Change %
+142%
Price
Shares after
97,205
Date
28 Jul 2026
Ownership
Direct
Footnotes
F1
PRTA transaction

Ordinary Shares, par value $0.01 per share

Disposed to Issuer

Transaction value
Shares
-57,000
Change %
-59%
Price
$8.56*
Shares after
40,205
Date
28 Jul 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PRTA transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-57,000
Change %
-100%
Price
$0.000000*
Shares after
0
Date
28 Jul 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
57,000
Exercise price
Footnotes
F1, F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's Ordinary Shares upon vesting.

Footnote F2

These RSUs reported in Table II were granted to the Reporting Person on July 28, 2025 as part of an aggregate award of 95,000 RSUs and initially reported in Table I of the Form 4 filed on July 30, 2025, because they were solely settleable in shares at the time of grant. These RSUs are being moved to Table II as of this Form 4.

Footnote F3

These RSUs reported in Table II are fully vested as of July 28, 2026 (the one-year anniversary of the grant date). The remainder of the 95,000 RSUs reported in Table I (38,000 RSUs) are subject to vesting.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .